pGEX-4T1 human PP2A B56α full length Citations (1)
Originally described in: Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth.Sangodkar J, Perl A, Tohme R, Kiselar J, Kastrinsky DB, Zaware N, Izadmehr S, Mazhar S, Wiredja DD, O'Connor CM, Hoon D, Dhawan NS, Schlatzer D, Yao S, Leonard D, Borczuk AC, Gokulrangan G, Wang L, Svenson E, Farrington CC, Yuan E, Avelar RA, Stachnik A, Smith B, Gidwani V, Giannini HM, McQuaid D, McClinch K, Wang Z, Levine AC, Sears RC, Chen EY, Duan Q, Datt M, Haider S, Ma'ayan A, DiFeo A, Sharma N, Galsky MD, Brautigan DL, Ioannou YA, Xu W, Chance MR, Ohlmeyer M, Narla G J Clin Invest. 2017 Jun 1;127(6):2081-2090. doi: 10.1172/JCI89548. Epub 2017 May 15. PubMed Journal
Articles Citing pGEX-4T1 human PP2A B56α full length
| Articles |
|---|
| Biochemical characterization of the Eya and PP2A-B55alpha interaction. Alderman C, Anderson R, Zhang L, Hughes CJ, Li X, Ebmeier C, Wagley ME, Ahn NG, Ford HL, Zhao R. J Biol Chem. 2024 Jul;300(7):107408. doi: 10.1016/j.jbc.2024.107408. Epub 2024 May 23. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.